Connect Biopharma Holdings Limited (CNTB)
Connect Biopharma Holdings Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Connect Biopharma Holdings Limited (CNTB) is a Biotechnology company based in CN with a market capitalization of $134.7M. Free cash flow was negative at -$51.6M. This page tracks CNTB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CN · 62 employees · IPO Mar 19, 2021
Valuation
Valuation & price
$2.40as of May 26, 2026· -35.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
3.21
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$134.7M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$51.6M
Free cash flow (USD)
-$43.7M
Net debt
Net cash position
0.8%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2024 → 2025
Value screen
Graham defensive-investor tests
1
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider buyJun 2, 2026Filing
Insider Buy $372KHuang James · Director · $371.6K
- 8-K eventMay 12, 2026Filing
Earnings Release
- Quarterly reportMay 12, 2026Filing
10-Q Filed
- 8-K eventApr 23, 2026Filing
Clinical Trial Update
- Insider buyApr 1, 2026Filing
Insider Buy $4.0MHuang James · Director · $4M
- 8-K eventMar 31, 2026Filing
Financial Results and Update
- Annual reportMar 31, 2026Filing
10-K Filed
Questions
Frequently asked questions
What is Connect Biopharma Holdings Limited's market cap?
Connect Biopharma Holdings Limited (CNTB) has a market capitalization of $134.7M.
What is CNTB's P/E ratio?
A meaningful P/E ratio is not available for CNTB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CNTB's price-to-book (P/B) ratio?
CNTB trades at 3.21 times book value per share.
Are insiders buying CNTB stock?
Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Connect Biopharma Holdings Limited in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.